Qinhuangdao hundred Hui Pharmaceutical Factory, Qinhuangdao Huang Wei Pharmaceutical and other enterprises capsule was exposed to excessive chromium

Hebei Province Food and Drug Administration 25th notified Hebei Province capsule drug supervision and sampling situation, 10 batches of products unqualified. Chromium over the medical capsule after the incident, in accordance with the unified deployment of the National Bureau, the Food and Drug Administration of Hebei province to 74 in the production of capsules pharmaceutical manufacturers conducted a full coverage of the supervision and testing, a total of 1109 batches of drug-testing capsules, 1099 batches of qualified products, unqualified products 10 batches. Unqualified products related to Hebei Shen Xing Group Seabuckthorn Pharmaceutical Co., Ltd., Hebei Long Live Pharmaceutical Co., Ltd., Qinhuangdao Hundred Hui Pharmaceutical Factory, Qinhuangdao Emperor Wei Pharmaceutical Co., Ltd., Shijiazhuang Kang Li Pharmaceutical Co., Ltd., Shijiazhuang City China New Drug Industry Co., Ltd., Hebei Kang Pharmaceutical Co., Ltd, Hanhan Berlin Pharmaceutical Co., Ltd. and other 8 enterprises. Hebei Province Food and Drug Administration, said that the Chinese Pharmacopoeia 2010 version before the implementation of the production of capsule drugs chromium content of the excess by the production enterprise active recall, not administrative punishment. Individual batches of chromium products are undergoing retest, retest results such as inconsistent with the results of the release, to retest after the results of the publication shall prevail. Chromium content exceeding the product Lot list serial number production Enterprise name Drug name production Lot No. 1 Hebei Shen Xing Group Seabuckthorn Pharmaceutical Co., Ltd. levofloxacin hydrochloride capsules 1112062 Hebei Long Live Pharmaceutical Co., Ltd. Waist pain capsule 1110013 Hebei Long Live Pharmaceutical Co., Ltd. Lumbar pain capsule 1111124 Qinhuangdao hundred Hui Pharmaceutical Factory hydrochloride capsules 201202015 Qin Emperor Huang Wei Pharmaceutical co., Ltd. 201202036 Shijiazhuang Kang Li Pharmaceutical Co., Ltd. ranitidine Hydrochloride Capsules 1107017 Shijiazhuang Kang Li Pharmaceutical Co., Ltd. hydrochloride capsules 1107028 Shijiazhuang City China New Drug Industry Co., Ltd. roxithromycin capsules 1103019 Hebei Kang Pharmaceutical Co., Ltd Norfloxacin Capsules 11070510 Hanhan hodginsii Lin Pharmaceutical Co., Ltd. artificial bezoar metronidazole capsules 100902 Chinese Pharmacopoeia 2010 version before the implementation of production Note: 1, the Chinese Pharmacopoeia 2010 version before the implementation of the production of capsule drugs chromium content of the excess of the active recall by the production enterprises, not administrative penalties. 2, individual batches of chromium products are retest, retest results such as inconsistent with the results of the release, to retest after the results of the release shall prevail.